
Leading Long COVID and related disease researchers are set to present updates to their work today at the PolyBio Research Foundation’s Fall 2025 Symposium. PolyBio supports some of the most highly-anticipated research projects in infection-associated chronic conditions (IACCs).

Leading scientists studying Long COVID and related chronic diseases are set to present updates to their work on Friday at the PolyBio Research Foundation’s Spring Symposium. The Sick Times’ team will be following the presentations throughout the day.

Last year, immunologist Johan Van Weyenbergh published a study in The Lancet: Microbe that identified a potential blood-based biomarker for Long COVID with 94% sensitivity. Van Weyenbergh’s team discovered SARS-CoV-2 RNA transcripts in the blood cells of people with Long COVID. They also found a specific type of RNA, called ORF1ab RNA, which suggested there…





advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance